Apremilast Add-On Benefits Over Conventional Drugs (ABCD) in Unstable Non-segmental Vitiligo: A 12-Week Single-Center Randomized Controlled Trial

Background Apremilast is an oral phosphodiesterase-4 enzyme inhibitor that modulates the immune system by increasing intracellular cyclic adenosine monophosphate levels and inhibiting inflammatory cytokines synthesis. We aimed to compare the efficacy and safety of add-on apremilast in combination th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Sakshi, Bhardwaj, Abhishek, Dwivedi, Pradeep, Yadav, Suraj Singh, Shamim, Muhammad Aaqib, Singh, Surjit, Sharma, Prem Prakash, Ambwani, Sneha, SIngh, Kuldeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162885/
https://www.ncbi.nlm.nih.gov/pubmed/37153322
http://dx.doi.org/10.7759/cureus.37180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162885/
https://www.ncbi.nlm.nih.gov/pubmed/37153322
http://dx.doi.org/10.7759/cureus.37180

Ejemplares similares